Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding

被引:73
作者
Harrison, RJ
Reszka, AP
Haider, SM
Romagnoli, B
Morrell, J
Read, MA
Gowan, SM
Incles, CM
Kelland, LR
Neidle, S
机构
[1] Univ London, Sch Pharm, Canc Res UK Biomol Struct Grp, London WC1N 1AX, England
[2] Inst Canc Res, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England
[3] Gen Hosp St Georg, Sch Med, Antisoma Res Labs, London, England
关键词
acridone; telomerase; quadruplex DNA;
D O I
10.1016/j.bmcl.2004.09.037
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and evaluation of a group of 2,6-, 2,7- and 3,6-bis-aminoalkylamido acridones are reported, which show a similar level of activity against telomerase in vitro compared to their acridine counterparts. Computer modelling and calculations of relative binding energies suggest an equivalent binding mode to human intramolecular G-quadruplex DNA, but with significantly reduced affinity; as a result of the limited delocalisation of the acridone chromophore compared to the acridine system. Thermal melting studies on acridone and acridine quadruplex complexes using a FRET approach support these predictions. Long-term cell proliferation studies at sub-cytotoxic doses with two representative acridones using the SKOV3 cell line, show that neither compound produces growth arrest, in contrast with the effects produced by the tri-substituted acridine compound BRACO-19. It is concluded that telomerase inhibitory activity is a necessary though by itself insufficient property in order for cellular growth arrest to occur at sub-toxic concentrations, and that tight quadruplex binding is also required. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5845 / 5849
页数:5
相关论文
共 31 条
[1]   Benzoindoloquinolines interact with DNA tetraplexes and inhibit telomerase [J].
Alberti, P ;
Schmitt, P ;
Nguyen, CH ;
Rivalle, C ;
Hoarau, M ;
Grierson, DS ;
Mergny, JL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (07) :1071-1074
[2]   Telomerase inhibition, oligonucleotides, and clinical trials [J].
Corey, DR .
ONCOGENE, 2002, 21 (04) :631-637
[3]   TELOMERASE ACTIVITY IN HUMAN OVARIAN-CARCINOMA [J].
COUNTER, CM ;
HIRTE, HW ;
BACCHETTI, S ;
HARLEY, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :2900-2904
[4]   A highly selective telomerase inhibitor limiting human cancer cell proliferation [J].
Damm, K ;
Hemmann, U ;
Garin-Chesa, P ;
Hauel, N ;
Kauffmann, I ;
Priepke, H ;
Niestroj, C ;
Daiber, C ;
Enenkel, B ;
Guilliard, B ;
Lauritsch, I ;
Müller, E ;
Pascolo, E ;
Sauter, G ;
Pantic, M ;
Martens, UM ;
Wenz, C ;
Lingner, J ;
Kraut, N ;
Rettig, WJ ;
Schnapp, A .
EMBO JOURNAL, 2001, 20 (24) :6958-6968
[5]   POTENTIAL ANTI-TUMOR AGENTS .36. QUANTITATIVE RELATIONSHIPS BETWEEN EXPERIMENTAL ANTI-TUMOR ACTIVITY, TOXICITY, AND STRUCTURE FOR THE GENERAL-CLASS OF 9-ANILINOACRIDINE ANTI-TUMOR AGENTS [J].
DENNY, WA ;
CAIN, BF ;
ATWELL, GJ ;
HANSCH, C ;
PANTHANANICKAL, A ;
LEO, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (03) :276-315
[6]   NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA [J].
Fedoroff, OY ;
Salazar, M ;
Han, HY ;
Chemeris, VV ;
Kerwin, SM ;
Hurley, LH .
BIOCHEMISTRY, 1998, 37 (36) :12367-12374
[7]   SYNTHESIS OF DIAMINOACRIDINES .1. [J].
GOLDBERG, AA ;
KELLY, W .
JOURNAL OF THE CHEMICAL SOCIETY, 1946, (FEB) :102-111
[8]   A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity [J].
Gowan, SM ;
Harrison, JR ;
Patterson, L ;
Valenti, M ;
Read, MA ;
Neidle, S ;
Kelland, LR .
MOLECULAR PHARMACOLOGY, 2002, 61 (05) :1154-1162
[9]   Inhibition of telomerase limits the growth of human cancer cells [J].
Hahn, WC ;
Stewart, SA ;
Brooks, MW ;
York, SG ;
Eaton, E ;
Kurachi, A ;
Beijersbergen, RL ;
Knoll, JHM ;
Meyerson, M ;
Weinberg, RA .
NATURE MEDICINE, 1999, 5 (10) :1164-1170
[10]   Human telomerase inhibition by substituted acridine derivatives [J].
Harrison, RJ ;
Gowan, SM ;
Kelland, LR ;
Neidle, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (17) :2463-2468